Active	Status	Sponsor type	Region	Phase	Filter
11 Active 8 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brodmann, Marianne
TRANSCEND, NCT03241459: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon	Active, not recruiting	N/A	446	Europe, US, RoW	Surmodics SurVeil DCB, Medtronic IN.PACT Admiral DCB	SurModics, Inc.	Peripheral Arterial Disease, Peripheral Vascular Disease, Artery Disease, Peripheral, Femoropopliteal Artery Occlusion	09/20	10/24
DEEPER LIMUS, NCT04162418: A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB	Completed	N/A	26	Europe	Temporary Spur Stent System	ReFlow Medical, Inc.	Peripheral Arterial Disease, Critical Limb Ischemia	06/22	09/23
HEAL, NCT04110327: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease	Recruiting	N/A	250	Europe	MicroStent	Micro Medical Solution, Inc.	Peripheral Arterial Disease, Peripheral Artery Disease, Critical Limb Ischemia, Critical Lower Limb Ischemia	07/23	01/24
NCT04525794: BRight DCB First-in-Human Study	Completed	N/A	48	Europe, RoW	BRight DCB	Biotronik CRC Inc., Biotronik AG	Peripheral Artery Disease	09/23	02/24
BIONETIC-I, NCT04830228: BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions	Active, not recruiting	N/A	160	Europe	Ballon expandable stent and PTA	Biotronik AG	Peripheral Artery Disease	02/23	02/28
NCT05055297: SELUTION4BTK Trial	Recruiting	N/A	376	Europe, US, RoW	SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA)	MedAlliance, LLC, NAMSA	Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities	11/24	07/28
PROSPECTORII, NCT03933657: Prospective Study of the SoundBite™ Crossing System in Complex Peripheral CTOs	Withdrawn	N/A	100	Europe	SoundBite™ Crossing System - Peripheral	SoundBite Medical Solutions, Inc., ethica Clinical Research Inc., Montreal Heart Institute	Peripheral Arterial Occlusive Disease, Chronic Total Occlusion of Artery of the Extremities	09/23	09/23
BIO-OSCAR SOC, NCT05831319: Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures	Recruiting	N/A	380	Europe		Biotronik AG	Peripheral Arterial Disease	05/24	07/24
RESOLV I, NCT04912323: Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease	Recruiting	N/A	30	Europe, Canada	Percutaneous Implantation of the MAGNITUDE® Bioresorbable Arterial Scaffold	R3 Vascular Inc., Massachusetts General Physicians Organization / Vascore, Cardiovascular Research Foundation, New York	Peripheral Arterial Disease, Atherosclerotic Lesion, Lower Extremity Ischemia, Lower Extremity Claudication	12/26	12/31
NCT05132361: SELUTION4SFA Trial	Recruiting	N/A	300	Europe, US, RoW	SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA)	MedAlliance, LLC, NAMSA	Peripheral Arterial Disease, Superficial Femoral Artery Stenosis	12/24	12/29
ELITE-BTK, NCT06071429: Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease	Not yet recruiting	N/A	300	NA	MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal Angioplasty (PTA)	R3 Vascular Inc.	Chronic Limb-Threatening Ischemia	03/28	03/32